microRNA-513c suppresses the proliferation of human glioblastoma cells by repressing low-density lipoprotein receptor-related protein 6

Xu,Jiajun; Sun,Tao; Hu,Xuebing

doi:10.3892/mmr.2015.3913

microRNA-513c suppresses the proliferation of human glioblastoma cells by repressing low-density lipoprotein receptor-related protein 6

Authors:
- Jiajun Xu
- Tao Sun
- Xuebing Hu
View Affiliations

Affiliations: Department of Neurosurgery, Shandong Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan, Shandong 250021, P.R. China, Department of Neurosurgery, Zaozhuang Hospital of Zaozhuang Coal Mining Group, Zaozhuang, Shandong 277101, P.R. China, Department of Neurosurgery, Tengzhou Workers Hospital, Tengzhou, Shandong 277500, P.R. China
Published online on: June 11, 2015 https://doi.org/10.3892/mmr.2015.3913
Pages: 4403-4409

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Aberrant activation of the Wnt/β-catenin signaling pathway is frequently observed in glioblastoma (GBM) cells. Therefore, it was hypothesized that low‑density lipoprotein receptor‑related protein 6 (LRP6) may be involved in activating the Wnt/β‑catenin pathway in the progression of GBM. The present study reported that the expression of microRNA (miR)‑513c was markedly downregulated in GBM cells and GBM tissues compared with that in normal human astrocytes and normal brain tissues. Previous studies have demonstrated that miR‑513c is critical in a variety of biological processes in various human cancer cells. The role of this miR in GBM cells was therefore investigated in the present study. Ectopic expression of miR‑513c reduced the proliferation and anchorage‑independent growth of GBM cells, whereas inhibition of miR‑513c promoted this effect. Bioinformatic analysis further identified LRP6, a putative tumor suppressor, as a potential target of miR‑513c. Luciferase reporter assays revealed that miR‑513c directly bound to the 3'‑untranslated region of LRP6 mRNA and repressed the expression at the transcriptional as well as the translational level. In functional assays, miR‑513c suppressed GBM cell proliferation, which was reversed by an inhibitor of miR‑513c. In conclusion, the present study provided compelling evidence that miR‑513c functions as a tumor suppressor miRNA, which may be important in the inhibition of cell proliferation in GBM. In addition, the tumor suppressive effects were mediated predominantly through the direct suppression of the expression of LRP6.

View Figures

View References

1	Wen PY and Kesari S: Malignant gliomas in adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
2	Baek D, Villén J, Shin C, Camargo FD, Gygi SP and Bartel DP: The impact of microRNAs on protein output. Nature. 455:64–71. 2008. View Article : Google Scholar : PubMed/NCBI
3	Bartel DP: MicroRNAs: Genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
4	Miska EA: How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev. 15:563–568. 2005. View Article : Google Scholar : PubMed/NCBI
5	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hsu SY, Kudo M, Chen T, et al: The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): Identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol. 14:1257–1271. 2000. View Article : Google Scholar : PubMed/NCBI
7	Li Y, Lu W, He X, Schwartz AL and Bu G: LRP6 expression promotes cancer cell proliferation and tumorigenesis by altering beta-catenin subcellular distribution. Oncogene. 23:9129–9135. 2004. View Article : Google Scholar : PubMed/NCBI
8	Lu W, Lin C, King TD, Chen H, Reynolds RC and Li Y: Silibinin inhibits Wnt/beta-catenin signaling by suppressing Wnt coreceptor LRP6 expression in human prostate and breast cancer cells. Cell Signal. 24:2291–2296. 2012. View Article : Google Scholar : PubMed/NCBI
9	Formosa A, Markert EK, Lena AM, et al: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32.31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 33:5173–5182. 2014. View Article : Google Scholar
10	Lehmann U, Streichert T, Otto B, et al: Identification of differentially expressed microRNAs in human male breast cancer. BMC Cancer. 10:1092010. View Article : Google Scholar : PubMed/NCBI
11	Gong X, Carmon KS, Lin Q, Thomas A, Yi J and Liu Q: LGR6 is a high affinity receptor of R-spondins and potentially functions as a tumor suppressor. PLoS One. 7:e371372012. View Article : Google Scholar : PubMed/NCBI
12	Gray JD, Kholmanskikh S, Castaldo BS, et al: LRP6 exerts non-canonical effects on Wnt signaling during neural tube closure. Hum Mol Genet. 22:4267–4281. 2013. View Article : Google Scholar : PubMed/NCBI
13	Joiner DM, Ke J, Zhong Z, Xu HE and Williams BO: LRP5 and LRP6 in development and disease. Trends Endocrinol Metab. 24:31–39. 2013. View Article : Google Scholar :
14	Maletínská L, Blakely EA, Bjornstad KA, Deen DF, Knoff LJ and Forte TM: Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res. 60:2300–2303. 2000.PubMed/NCBI
15	Semënov MV, Zhang X and He X: DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J Biol Chem. 283:21427–21432. 2008. View Article : Google Scholar : PubMed/NCBI
16	Ochoa-Hernández AB, Juárez-Vázquez CI, Rosales-Reynoso MA and Barros-Núñez P: WNT-β-catenin signaling pathway and its relationship with cancer. Cir Cir. 80:389–398. 2012.In Spanish.
17	Kim KH, Seol HJ, Kim EH, et al: Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol. 15:161–171. 2013. View Article : Google Scholar :
18	Hsieh IS, Chang KC, Tsai YT, et al: MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Carcinogenesis. 34:530–538. 2013. View Article : Google Scholar
19	Fu Y, Zheng S, An N, et al: β-catenin as a potential key target for tumor suppression. Int J Cancer. 129:1541–1551. 2011. View Article : Google Scholar : PubMed/NCBI
20	Chocarro-Calvo A, García-Martínez JM, Ardila-González S, De la Vieja A and García-Jiménez C: Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. Mol Cell. 49:474–486. 2013. View Article : Google Scholar : PubMed/NCBI
21	Wang D, Wise ML, Li F and Dey M: Phytochemicals attenuating aberrant activation of β-catenin in cancer cells. PLoS One. 7:e505082012. View Article : Google Scholar
22	He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
23	Kolligs FT, Bommer G and Göke B: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion. 66:131–144. 2002. View Article : Google Scholar : PubMed/NCBI
24	Nagayama M, Iwamoto M, Hargett A, et al: Wnt/beta-catenin signaling regulates cranial base development and growth. J Dent Res. 87:244–249. 2008. View Article : Google Scholar : PubMed/NCBI
25	Huang FI, Chen YL, Chang CN, Yuan RH and Jeng YM: Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion. Carcinogenesis. 33:1142–1148. 2012. View Article : Google Scholar : PubMed/NCBI
26	Planutiene M, Planutis K and Holcombe RF: Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metal-loproteinase-2 expression and promotes endothelial cell invasion. Vasc Cell. 3:282011. View Article : Google Scholar